Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.
The FDA has introduced models intended to accelerate rare disease drug development, but recent reversals of guidance from the ...
A Mintz newsletter tracking rapid changes in policy and agency actions that impact medical, life sciences, and ...
Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, ...
A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the ...
Eli Lilly's work in diabetes and weight loss is doing most of the heavy lifting right now. The company's financial results ...
Researchers at The University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects DNA from ...
SAN DIEGO, CA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Which CRO Is Good at Protein Degradation? Key ...
U.S. President Donald Trump's executive order to accelerate psychedelic drug development has raised hopes among companies ...
Bingchuan Wei of Genentech explains how HIC-MS integrates separation and mass detection to resolve and quantify individual ...
Provides End-To-End Services for Preclinical & Clinical Projects with Extensive Experience in Decoding Biologics Production ...
CDSCO allows parallel submission and processing of clinical trial applications: Our Bureau, New Delhi Monday, May 18, 2026, 08:00 Hrs [IST] In a significant move to address one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results